Sinohealth Holdings Limited (HKG:2361)
Hong Kong · Delayed Price · Currency is HKD 3.430
+0.110 (3.31%)
At close: Aug 22, 2025, 4:00 PM HKT
Sinohealth Holdings Revenue
In the year 2024, Sinohealth Holdings had annual revenue of 403.73M CNY with 1.90% growth. Sinohealth Holdings had revenue of 244.20M in the half year ending December 31, 2024, with 3.71% growth.
Revenue
403.73M CNY
Revenue Growth
+1.90%
P/S Ratio
3.26
Revenue / Employee
525.69K CNY
Employees
768
Market Cap
1.40B HKD
Revenue Chart
* This company reports financials in CNY.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 403.73M | 7.53M | 1.90% |
| Dec 31, 2023 | 396.19M | 39.53M | 11.08% |
| Dec 31, 2022 | 356.67M | 32.50M | 10.03% |
| Dec 31, 2021 | 324.17M | 122.09M | 60.42% |
| Dec 31, 2020 | 202.07M | 24.32M | 13.68% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| BeOne Medicines | 35.81B |
| Hansoh Pharmaceutical Group Company | 14.45B |
| JD Health International | 71.34B |
| Innovent Biologics | 10.03B |
| Akeso | 2.26B |
| Sino Biopharmaceutical | 33.49B |
| WuXi Biologics | 21.98B |
| CSPC Pharmaceutical Group | 28.99B |